MetaCap

Xenon Pharmaceuticals (XENE) News

NASDAQ: XENEHealth CareBiotechnology: Pharmaceutical PreparationsUSD

37.04-0.52 (-1.38%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

XENE news summary

We found 8 recent headlines mentioning Xenon Pharmaceuticals (XENE): 0 in the past week and 7 in the past 30 days, most often from GlobeNewswire, Nasdaq, Investing.com. For price context, XENE is down 1.38% at $37.04. The most recent story, "Xenon Reports Q3 Results; Expects X-NOVA2 Data In December And Advances Pain Programs Toward Phase 2", was published by Nasdaq on Nov 10, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Xenon Pharmaceuticals headlines

Stocks mentioned alongside XENE

Compare XENE